Reasonable Application of Antiviral Drugs in the Treatment of COVID-19

XU Xiaohan; ZHAI Suodi; YANG Li

doi:10.14009/j.issn.1672-2124.2020.02.001

您当前的位置：

首页 >

文章列表页 >

Reasonable Application of Antiviral Drugs in the Treatment of COVID-19

更新时间：2022-10-08

- Reasonable Application of Antiviral Drugs in the Treatment of COVID-19
- Vol. 20, Issue 2, Pages: 129-133(2020)
- 作者机构：
  
  北京大学第三医院药剂科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.02.001
  CLC： R969.3
- Published：2020，
扫描看全文
[1]徐晓涵,翟所迪,杨丽.新型冠状病毒肺炎治疗中抗病毒药物的合理使用[J].中国医院用药评价与分析,2020,20(02):129-133+139.

XU Xiaohan, ZHAI Suodi, YANG Li. Reasonable Application of Antiviral Drugs in the Treatment of COVID-19. [J]. 20(2):129-133(2020)
[1]徐晓涵,翟所迪,杨丽.新型冠状病毒肺炎治疗中抗病毒药物的合理使用[J].中国医院用药评价与分析,2020,20(02):129-133+139. DOI： 10.14009/j.issn.1672-2124.2020.02.001.

XU Xiaohan, ZHAI Suodi, YANG Li. Reasonable Application of Antiviral Drugs in the Treatment of COVID-19. [J]. 20(2):129-133(2020) DOI： 10.14009/j.issn.1672-2124.2020.02.001.

摘要

2019年12月以来

随着严重急性呼吸综合征冠状病毒2型（severe acute respiratory syndrome coronavirus 2

SARS-CoV-2）所致的疫情蔓延和对其认识的加深

药物治疗方案得到越来越多的关注

不断被改进更新。为了加强药学服务协助疫情防控

本文针对目前国家卫生健康委员会推荐的《新型冠状病毒肺炎诊疗方案（试行第六版）》抗病毒药α干扰素、洛匹那韦/利托那韦、利巴韦林、阿比多尔和磷酸氯喹

结合现有研究资料汇总合理使用具体注意点

供各医疗机构在新型冠状病毒肺炎（corona virus disease-19

COVID-19）诊疗中参考。

Abstract

Since December 2019

with the spread and deepening awareness of COVID-19 caused by SARS-CoV-2

pharmaceutical treatment received more and more attention

and are constantly being improved and updated. In order to strengthen pharmaceutical services to assist in epidemic prevention and control

this article targets the currently recommended antiviral chemicals: interferon-α

lopinavir/ritonavir

ribavirin

abidol and chloroquine phosphate. There are specific attention points for reasonable use based on research data for reference in COVID-19 diagnosis and treatment.

关键词

新型冠状病毒肺炎药物治疗α干扰素洛匹那韦/利托那韦利巴韦林阿比多尔磷酸氯喹

Keywords

COVID-19PharmacotherapyInterferon-αLopinavir/ritonavirRibavirinAbidolChloroquine phosphate

references

查看原文

Views

1110

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Systematic Review of Efficacy and Safety of Lopinavir/Ritonavir in Patients with COVID-19

Retrospective Study of Efficacy and Safety of Lianhua Qingwen Granules Combined with Lopinavir/Ritonavir in the Treatment of COVID-19

Comparison of Efficacy and Safety of Chloroquine Phosphate and Lopinavir/Ritonavir in the Treatment of Patients with COVID-19

Systematic Review on Efficacy and Safety of Ribavirin in the Treatment of Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome

Progress of Antiviral Research of Arbidol

Related Author

WU Xiayang

WU Xiuping

BAI Xue

夏一淼

王法财

沈炳香

聂松柳

LIAO Shixiong

Related Institution

Dept.of Pharmacy,Xiamen Children’s Hospital

Lu’an People’s Hospital

Dept. of Pharmacy,the First Maternal and Child Health Hospital of Huizhou

Dept. of Pharmacy,Huizhou Central People’s Hospital

Institute for Drug Evaluation, Peking University Health Science Center

⁰